Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

36.98 +0.93 (+2.58%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
47 48 Next >
News headline image
Missed the Hims & Hers Rally? Clover Health Could Be Next
After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space. 
Via MarketBeat
News headline image
EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank? ↗
These were the 20 tickers that Benzinga readers searched for the most during the month of February. 
Via Benzinga
News headline image
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath ↗
U.S. markets suffered a steep selloff Monday as President Donald Trump announced sweeping new tariffs, extending last week's losses and driving declines across all major sectors. 
Via Benzinga
Topics Government World Trade
News headline image
Why Hims & Hers Health Stock Sank This Week ↗
Via The Motley Fool
News headline image
Hims & Hers Health Unusual Options Activity For February 28 ↗
 
Via Benzinga
News headline image
Short Term Relief Likely ↗
Post earnings has seen little bullish follow-through, and this typically means the broad market won’t have much to shout about over the coming weeks. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? ↗
Via The Motley Fool
News headline image
Sixty Percent Of The Time, It Works Every Time ↗
​​​​​​​The past few weeks have brought a dramatic change in investor sentiment. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up ↗
Can Hims & Hers Health recover after the FDA removed semaglutide from its drugs shortage list? 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Hims Stock Crashed After Earnings. What Went Wrong? ↗
Via The Motley Fool
News headline image
NVDA Earnings And The State Of The Market ↗
Nvidia reported its much anticipated 4Q earnings after the close. It was a mixed bag. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Why Hims & Hers Stock Rebounded on Wednesday ↗
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now
See why these two high-flying stocks are among the most shorted in the market, plus counterarguments amid bearish gripes. 
Via MarketBeat
News headline image
GoodRx Earnings: What To Look For From GDRX
Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know. 
Via StockStory
News headline image
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Hims & Hers Health Analyst Sees Buying Opportunity Following Steep Selloff: 'We See No Reason To Change Our View' ↗
Hims & Hers Health Inc. (NYSE: HIMS) shares dropped sharply after the company reported its fourth-quarter earnings. Here's what you need to know. 
Via Benzinga
News headline image
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected,... 
Via StockStory
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday? ↗
Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a... 
Via Benzinga
Topics Stocks
News headline image
Hims & Hers Stock Crashed 26% Today. Here's What You Need to Know ↗
Hims & Hers grew 95% in the fourth quarter of 2024, but investors were worried about GLP-1 growth. 
Via The Motley Fool
News headline image
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
Hims & Hers Health Stock Is Plunging Tuesday: What's Going On? ↗
Hims & Hers Health reported fourth-quarter revenue of $481.14 million, beating estimates of $470.31 million, according to Benzinga Pro. The company reported fourth-quarter earnings of 11 cents per... 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect. 
Via StockStory
News headline image
Markets Mostly Dip Red Late In Regular Trading ↗
Market indexes drooped in the final minutes of the normal trading day to start a new week, with all major indexes save the blue-chip Dow closing in the red, adding to Friday’s losses. 
Via Talk Markets
Topics Stocks Stocks / Equities
News headline image
Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗
On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide. 
Via Stocktwits
Topics Earnings
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat ↗
Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter. 
Via Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.